Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas C. Harding currently holds 18,590 shares of Clovis Oncology, Inc. (CLVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas C. Harding has been a net seller of CLVS stock. They have purchased $0 and sold $165.8K worth of shares.
Thomas C. Harding's most recent insider trade was on Nov 2, 2022, when they sold 788 shares at $0.98 per share.
Thomas C. Harding serves as Executive at Clovis Oncology, Inc. (CLVS). They have executed 98 insider transactions totaling $165.8K over their tenure at the company.
Thomas C. Harding holds the position of Executive at Clovis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Thomas C. Harding has shown a selling trading pattern, with $0 in total purchases and $165.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas C. Harding was on Mar 2, 2022, when they sold $12.7K worth of CLVS shares. This transaction involved 6,780 shares at $1.87 per share.
Thomas C. Harding currently owns 18,590 shares of Clovis Oncology, Inc. (CLVS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas C. Harding's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas C. Harding has 98 Form 4 filings on record as an insider at Clovis Oncology, Inc..
Set alerts for Thomas C. Harding and 40,000+ other insiders.